$SER
Serina Therapeutics Inc Stock $ser

$ser Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000149315222022361 Filed on August 12, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2021 Q4
Revenue	$9.000K	$12.00K	$27.00K
YoY Change	-62.5%	-67.57%	-82.91%
Cost Of Revenue	$5.000K	$6.000K	$1.000K
YoY Change	150.0%	-53.85%	-80.0%
Gross Profit	$4.000K	$6.000K	$26.00K
YoY Change	-81.82%	-75.0%	-83.01%
Gross Profit Margin	44.44%	50.0%	96.3%
Selling, General & Admin	$1.392M	$1.338M	$1.517M
YoY Change	-2.04%	-23.46%	-3.68%
% of Gross Profit	34800.0%	22300.0%	5834.62%
Research & Development	$162.0K	$259.0K	$343.0K
YoY Change	-33.33%	-46.15%	-60.57%
% of Gross Profit	4050.0%	4316.67%	1319.23%
Depreciation & Amortization	$33.00K	$33.00K	$33.00K
YoY Change	3.13%	0.0%	-92.96%
% of Gross Profit	825.0%	550.0%	126.92%
Operating Expenses	$1.554M	$1.597M	$1.893M
YoY Change	-8.37%	-28.35%	-23.67%
Operating Profit	-$1.550M	-$1.591M	-$1.867M
YoY Change	-7.41%	-27.85%	-19.77%
Interest Expense	$923.0K	-$863.0K	-$295.0K
YoY Change	-423.86%	214.96%	62.09%
% of Operating Profit
Other Income/Expense, Net	-$886.0K	-$1.027M	$3.000K
YoY Change	-22250.0%	280.37%	-96.97%
Pretax Income	-$2.436M	-$2.618M	-$2.159M
YoY Change	24.6%	5.78%	-10.41%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$2.435M	-$2.618M	-$2.158M
YoY Change	24.55%	5.82%	-11.77%
Net Earnings / Revenue	-27055.56%	-21816.67%	-7992.59%
Basic Earnings Per Share	-$0.06	-$0.07
Diluted Earnings Per Share	-$64.17K	-$69.00K	-$56.88K
COMMON SHARES
Basic Shares Outstanding	37.95M shares	37.94K shares
Diluted Shares Outstanding	37.95K shares	37.94K shares

Balance Sheet

Concept	2022 Q3	2022 Q2	2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$466.0K	$702.0K	$584.0K
YoY Change	-36.25%	14.15%	10.82%
Cash & Equivalents	$466.0K	$702.0K	$584.0K
Short-Term Investments
Other Short-Term Assets	$720.0K	$1.011M	$1.625M
YoY Change	0.0%	8.71%	13.64%
Inventory
Prepaid Expenses
Receivables	$1.000K	$12.00K	$25.00K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$1.187M	$1.725M	$2.234M
YoY Change	-19.53%	10.86%	-2.15%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles	$771.0K	$804.0K	$870.0K
YoY Change
Long-Term Investments
YoY Change
Other Assets	$50.00K	$50.00K	$50.00K
YoY Change	0.0%	0.0%	0.0%
Total Long-Term Assets	$821.0K	$854.0K	$920.0K
YoY Change	-13.76%	-13.3%	-43.97%
TOTAL ASSETS
Total Short-Term Assets	$1.187M	$1.725M	$2.234M
Total Long-Term Assets	$821.0K	$854.0K	$920.0K
Total Assets	$2.008M	$2.579M	$3.154M
YoY Change	-17.26%	1.5%	-19.64%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$351.0K	$161.0K	$193.0K
YoY Change	90.76%	-66.67%	-74.64%
Accrued Expenses	$441.0K	$521.0K	$578.0K
YoY Change	-40.41%	-36.39%	-35.42%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Long-Term Debt Due	$7.298M	$6.968M	$7.140M
YoY Change	30.32%	95.73%	264.29%
Total Short-Term Liabilities	$8.809M	$9.085M	$8.967M
YoY Change	33.51%	72.36%	67.39%
LONG-TERM LIABILITIES
Long-Term Debt	$8.348M	$6.756M	$6.062M
YoY Change	43.76%	21.42%	55.44%
Other Long-Term Liabilities			$0.00
YoY Change			-100.0%
Total Long-Term Liabilities	$8.348M	$6.756M	$6.062M
YoY Change	43.76%	21.42%	52.93%
TOTAL LIABILITIES
Total Short-Term Liabilities	$8.809M	$9.085M	$8.967M
Total Long-Term Liabilities	$8.348M	$6.756M	$6.062M
Total Liabilities	$17.16M	$15.84M	$15.03M
YoY Change	38.78%	46.77%	66.23%
SHAREHOLDERS EQUITY
Retained Earnings	-$113.5M	-$111.1M	-$105.7M
YoY Change
Common Stock	$4.000K	$4.000K	$4.000K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$15.10M	-$13.22M	-$11.83M
YoY Change
Total Liabilities & Shareholders Equity	$2.008M	$2.579M	$3.154M
YoY Change	-17.26%	1.5%	-19.64%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2021 Q4
OPERATING ACTIVITIES
Net Income	-$2.435M	-$2.618M	-$2.158M
YoY Change	24.55%	5.82%	-11.77%
Depreciation, Depletion And Amortization	$33.00K	$33.00K	$33.00K
YoY Change	3.13%	0.0%	-92.96%
Cash From Operating Activities	-$1.236M	-$1.746M	-$1.647M
YoY Change	-34.39%	3.07%	1.67%
INVESTING ACTIVITIES
Capital Expenditures			$0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$250.0K
YoY Change
Cash From Investing Activities	$0.00	$0.00	$250.0K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.000M	2.000M	1.250M
YoY Change	-50.0%	33.33%	26.01%
NET CHANGE
Cash From Operating Activities	-1.236M	-1.746M	-1.647M
Cash From Investing Activities	0.000	0.000	250.0K
Cash From Financing Activities	1.000M	2.000M	1.250M
Net Change In Cash	-236.0K	254.0K	-147.0K
YoY Change	-303.45%	-230.93%	-76.59%
FREE CASH FLOW
Cash From Operating Activities	-$1.236M	-$1.746M	-$1.647M
Capital Expenditures			$0.00
Free Cash Flow			-$1.647M
YoY Change			1.67%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	8967000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	805000	usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001708599
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021Q4	AGE	Warrant Liability WarrantLiability		usd
CY2022Q2	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount		usd
CY2021Q2	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount		usd
CY2021Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		usd
CY2022Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax		usd
CY2021Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax		usd
CY2021Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Noncontrolling Interest IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest		usd
CY2022Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
CY2021Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
CY2022Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity		usd
CY2021Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity		usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax		usd
CY2021Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax		usd
CY2022Q2	AGE	Other Comprehensive Income Loss Attributable To Noncontrolling Interest From Continuing Operations OtherComprehensiveIncomeLossAttributableToNoncontrollingInterestFromContinuingOperations		usd
CY2022Q2	AGE	Other Comprehensive Income Loss Attributable To Noncontrolling Interest From Discontinued Operations OtherComprehensiveIncomeLossAttributableToNoncontrollingInterestFromDiscontinuedOperations		usd
CY2021Q2	AGE	Other Comprehensive Income Loss Attributable To Noncontrolling Interest From Discontinued Operations OtherComprehensiveIncomeLossAttributableToNoncontrollingInterestFromDiscontinuedOperations		usd
	AGE	Deconsolidation Gain Or Loss Amount One DeconsolidationGainOrLossAmountOne		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		usd
	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations		usd
	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments		usd
	us-gaap	Proceeds From Collection Of Longterm Loans To Related Parties ProceedsFromCollectionOfLongtermLoansToRelatedParties		usd
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations		usd
	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations		usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations		usd
CY2021Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
CY2021Q4	AGE	Warrant Liability WarrantLiability		usd
	AGE	Unrealized Loss On Change In Fair Value Of Warrants UnrealizedLossOnChangeInFairValueOfWarrants		usd
	AGE	Unrealized Loss On Change On Other Than Options UnrealizedLossOnChangeOnOtherThanOptions		shares
	AGE	Unrealized Loss On Change In Fair Value Of Warrants Per Share UnrealizedLossOnChangeInFairValueOfWarrantsPerShare
	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions		usd
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
	us-gaap	Assets Fair Value Adjustment AssetsFairValueAdjustment		usd
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.0001 per share
	dei	Trading Symbol TradingSymbol	AGE
	dei	Security Exchange Name SecurityExchangeName	NYSE
	us-gaap	Short Term Debt Refinanced Amount ShortTermDebtRefinancedAmount		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
	dei	City Area Code CityAreaCode	(510)
CY2021Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding		shares
	dei	Local Phone Number LocalPhoneNumber	671-8370
CY2021Q4	AGE	Insurance Premium Liability And Other Liabilities Current InsurancePremiumLiabilityAndOtherLiabilitiesCurrent	986000	usd
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	1-38519
	dei	Entity Registrant Name EntityRegistrantName	AgeX Therapeutics, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	82-1436829
	dei	Entity Address Address Line1 EntityAddressAddressLine1	1101 Marina Village Parkway
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 201
	dei	Entity Address City Or Town EntityAddressCityOrTown	Alameda
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94501
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	true
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	37945108	shares
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	702000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	584000	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	12000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	25000	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1011000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1625000	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	1725000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	2234000	usd
CY2022Q2	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	50000	usd
CY2021Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	50000	usd
CY2022Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	804000	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	870000	usd
CY2022Q2	us-gaap	Assets Assets	2579000	usd
CY2021Q4	us-gaap	Assets Assets	3154000	usd
CY2022Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	682000	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	771000	usd
CY2022Q2	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	6968000	usd
CY2021Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	7140000	usd
CY2022Q2	AGE	Related Party Payables Net RelatedPartyPayablesNet	69000	usd
CY2021Q4	AGE	Related Party Payables Net RelatedPartyPayablesNet	70000	usd
CY2022Q2	AGE	Warrant Liability WarrantLiability	1033000	usd
CY2022Q2	AGE	Insurance Premium Liability And Other Liabilities Current InsurancePremiumLiabilityAndOtherLiabilitiesCurrent	333000	usd
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	9085000	usd
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	37945000	shares
CY2022Q2	us-gaap	Due To Related Parties Noncurrent DueToRelatedPartiesNoncurrent	6756000	usd
CY2021Q4	us-gaap	Due To Related Parties Noncurrent DueToRelatedPartiesNoncurrent	6062000	usd
CY2022Q2	us-gaap	Liabilities Liabilities	15841000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	15029000	usd
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	37945000	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	37941000	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	37941000	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	4000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	4000	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	97850000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	93912000	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-111072000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-105748000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-13218000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-11832000	usd
CY2022Q2	us-gaap	Minority Interest MinorityInterest	-44000	usd
CY2021Q4	us-gaap	Minority Interest MinorityInterest	-43000	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-13262000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-11875000	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2579000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3154000	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	12000	usd
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	37000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	17000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	93000	usd
CY2022Q2	us-gaap	Cost Of Revenue CostOfRevenue	6000	usd
CY2021Q2	us-gaap	Cost Of Revenue CostOfRevenue	13000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	7000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	16000	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	6000	usd
CY2021Q2	us-gaap	Gross Profit GrossProfit	24000	usd
	us-gaap	Gross Profit GrossProfit	10000	usd
	us-gaap	Gross Profit GrossProfit	77000	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	259000	usd
CY2021Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	481000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	255000	usd
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-517000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	655000	usd
CY2022Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	168000	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1338000	usd
CY2021Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1748000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2998000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3770000	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	1597000	usd
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	2229000	usd
	us-gaap	Operating Expenses OperatingExpenses	3653000	usd
	us-gaap	Operating Expenses OperatingExpenses	4575000	usd
	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	106000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1591000	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2205000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-3643000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-4392000	usd
CY2022Q2	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-863000	usd
CY2021Q2	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-274000	usd
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-1434000	usd
CY2022Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	4000	usd
CY2021Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	4000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	7000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	441000	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1027000	usd
CY2021Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-270000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1682000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-76000	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2618000	usd
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2475000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5325000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4468000	usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-103000	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-2618000	usd
CY2021Q2	us-gaap	Profit Loss ProfitLoss	-2475000	usd
	us-gaap	Profit Loss ProfitLoss	-5325000	usd
	us-gaap	Profit Loss ProfitLoss	-4571000	usd
CY2021Q2	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	1000	usd
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	1000	usd
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	2000	usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Noncontrolling Interest IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest	-7000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-2618000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-2474000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-5324000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4562000	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.07
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	37943	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	37936	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	37943	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	37833	shares
CY2021Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.07
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.14
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-5325000	usd
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.12
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4714000	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-2618000	usd
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
CY2021Q2	AGE	Other Comprehensive Income Loss Attributable To Noncontrolling Interest From Continuing Operations OtherComprehensiveIncomeLossAttributableToNoncontrollingInterestFromContinuingOperations	1000	usd
	AGE	Other Comprehensive Income Loss Attributable To Noncontrolling Interest From Continuing Operations OtherComprehensiveIncomeLossAttributableToNoncontrollingInterestFromContinuingOperations	1000	usd
CY2021Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2475000	usd
	us-gaap	Increase Decrease In Insurance Liabilities IncreaseDecreaseInInsuranceLiabilities	-653000	usd
CY2021Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-2474000	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-5324000	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-4466000	usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-96000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-2618000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-2474000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-5324000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4562000	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-2618000	usd
CY2021Q2	us-gaap	Profit Loss ProfitLoss	-2475000	usd
	us-gaap	Profit Loss ProfitLoss	-5325000	usd
	us-gaap	Profit Loss ProfitLoss	-4571000	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-143000	usd
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2618000	usd
	AGE	Other Comprehensive Income Loss Attributable To Noncontrolling Interest From Continuing Operations OtherComprehensiveIncomeLossAttributableToNoncontrollingInterestFromContinuingOperations	2000	usd
	AGE	Other Comprehensive Income Loss Attributable To Noncontrolling Interest From Discontinued Operations OtherComprehensiveIncomeLossAttributableToNoncontrollingInterestFromDiscontinuedOperations	7000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-2618000	usd
CY2021Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-2474000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-5324000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-4705000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	5324000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	4466000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-2000	usd
	AGE	Deconsolidation Gain Or Loss Amount One DeconsolidationGainOrLossAmountOne	106000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	437000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	255000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	66000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	66000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1355000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	537000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	437000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	464000	usd
	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	-13000	usd
	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	-142000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-614000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-472000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-207000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-242000	usd
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	65000	usd
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	25000	usd
	us-gaap	Increase Decrease In Insurance Liabilities IncreaseDecreaseInInsuranceLiabilities	-611000	usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-2000	usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-76000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3746000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	118000	usd
CY2022Q2	us-gaap	Common Stock Held By Subsidiary CommonStockHeldBySubsidiary	250000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-3382000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-4234000	usd
	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-90000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3382000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4324000	usd
	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	466000	usd
	us-gaap	Proceeds From Collection Of Longterm Loans To Related Parties ProceedsFromCollectionOfLongtermLoansToRelatedParties	250000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	716000	usd
	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	-50000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	666000	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	3500000	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	3500000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	496000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	3500000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	3996000	usd
	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations	-250000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3500000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	88000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	634000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	577000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	752000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	665000	usd
CY2022Q2	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	700000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84F_eus-gaap--UseOfEstimates_z931MHtx3xW9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86F_zkbmg4rHbvNd">Use of estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statement and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from the estimates. See Note 6 for discussion on estimated unrealized loss on change in fair value of warrant liability.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q2	AGE	Warrant Liability WarrantLiability	1033000	usd
CY2021Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	33000	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	702000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	584000	usd
CY2022Q2	us-gaap	Restricted Cash Equivalents RestrictedCashEquivalents	50000	usd
CY2021Q4	us-gaap	Restricted Cash Equivalents RestrictedCashEquivalents	50000	usd
CY2022Q2	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	752000	usd
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	634000	usd
CY2020Q4	us-gaap	Payments For Rent PaymentsForRent	947	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1312000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1312000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	508000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	442000	usd
CY2022Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	804000	usd
	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue	277000	usd
	us-gaap	Disposal Group Including Discontinued Operation Operating Expense DisposalGroupIncludingDiscontinuedOperationOperatingExpense	-380000	usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-103000	usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Noncontrolling Interest IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest	-7000	usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-96000	usd
	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	106000	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	870000	usd
CY2022Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	33000	usd
CY2022Q2	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	348000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	66000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	66000	usd
	us-gaap	Depreciation And Amortization Discontinued Operations DepreciationAndAmortizationDiscontinuedOperations	89000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	65000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	131000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	131000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	132000	usd
CY2022Q2	AGE	Finite Lived Intangible Assets Amortization Expense After Year Three FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearThree	345000	usd
CY2022Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	804000	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	161000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	193000	usd
CY2022Q2	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	173000	usd
CY2021Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	212000	usd
CY2021Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	366000	usd
CY2022Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	682000	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	771000	usd
	AGE	Changes In Fair Value ChangesInFairValue	255000	usd
CY2022Q2	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	3000000	usd
CY2022Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	2500000	shares
CY2022Q2	us-gaap	Secured Debt SecuredDebt	13160000	usd
CY2022Q2	us-gaap	Secured Debt SecuredDebt	13160000	usd
CY2022Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.4132
CY2022Q2	AGE	Warrant Liability WarrantLiability	1033000	usd
CY2022Q2	AGE	Changes In Fair Value Of Warant Liability ChangesInFairValueOfWarantLiability	168000	usd
	AGE	Changes In Fair Value Of Warant Liability ChangesInFairValueOfWarantLiability	255000	usd
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	37945108	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	37945108	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	37941220	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	37941220	shares
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-11591000	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-11591000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	-1000	usd
CY2022Q2	AGE	Fair Value Of Liability Classified Warrants Issued FairValueOfLiabilityClassifiedWarrantsIssued	750000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	198000	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-2618000	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-13262000	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-13262000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-11875000	usd
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	286000	usd
CY2021Q2	us-gaap	Profit Loss ProfitLoss	-2475000	usd
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-8294000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-11875000	usd
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-8294000	usd
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-5396000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0174	pure
	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	-2000	usd
	AGE	Fair Value Of Warrants Issued FairValueOfWarrantsIssued	178000	usd
	AGE	Fair Value Of Liability Classified Warrants Issued FairValueOfLiabilityClassifiedWarrantsIssued	3325000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	437000	usd
	us-gaap	Profit Loss ProfitLoss	-5325000	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-13262000	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-13262000	usd
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-6103000	usd
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-6103000	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	-2000	usd
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-5396000	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	475000	usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	-5000	usd
	AGE	Fair Value Of Warrants Issued FairValueOfWarrantsIssued	757000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	468000	usd
	AGE	Deconsolidation Of Lifemap Sciences DeconsolidationOfLifemapSciences	-22000	usd
	us-gaap	Profit Loss ProfitLoss	-4571000	usd
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-8294000	usd
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-8294000	usd
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.71
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.46
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.79
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.46
CY2022Q2	us-gaap	Accelerated Share Repurchases Final Price Paid Per Share AcceleratedShareRepurchasesFinalPricePaidPerShare	0.71
CY2021Q2	us-gaap	Accelerated Share Repurchases Final Price Paid Per Share AcceleratedShareRepurchasesFinalPricePaidPerShare	1.46
	us-gaap	Accelerated Share Repurchases Final Price Paid Per Share AcceleratedShareRepurchasesFinalPricePaidPerShare	0.79
	us-gaap	Accelerated Share Repurchases Final Price Paid Per Share AcceleratedShareRepurchasesFinalPricePaidPerShare	1.46
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y29D
CY2021Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y8M15D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y6M29D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y8M15D
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.2835	pure
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.0234	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.3071	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.0234	pure
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0290	pure
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0099	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0099	pure
CY2022Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	198000	usd
CY2021Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	286000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	437000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	464000	usd
	AGE	Share Based Compensation From Discontinued Operations ShareBasedCompensationFromDiscontinuedOperations	4000	usd
	us-gaap	Interest Paid Net InterestPaidNet	12000	usd
	us-gaap	Interest Paid Net InterestPaidNet	11000	usd
	AGE	Issuance Of Common Stock Upon Vesting Of Restricted Stock Units IssuanceOfCommonStockUponVestingOfRestrictedStockUnits	5000	usd
	AGE	Issuance Of Common Stock Upon Vesting Of Restricted Stock Units IssuanceOfCommonStockUponVestingOfRestrictedStockUnits	11000	usd
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	178000	usd
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	757000	usd
	us-gaap	Assets Fair Value Adjustment AssetsFairValueAdjustment	3325000	usd
	us-gaap	Short Term Debt Refinanced Amount ShortTermDebtRefinancedAmount	7160000	usd
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	2000000	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest		usd
CY2022Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Noncontrolling Interest IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest		usd

Files In Submission

Name	View Source	Status
0001493152-22-022361-index-headers.html	Edgar Link	pending
0001493152-22-022361-index.html	Edgar Link	pending
0001493152-22-022361.txt	Edgar Link	pending
0001493152-22-022361-xbrl.zip	Edgar Link	pending
age-20220630.xsd	Edgar Link	pending
ex31.htm	Edgar Link	pending
ex32.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
age-20220630_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
age-20220630_pre.xml	Edgar Link	unprocessable
age-20220630_lab.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
age-20220630_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SER
Serina Therapeutics Inc Stock $ser

2022 Q3 Form 10-Q Financial Statement

#000149315222022361 Filed on August 12, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SER Serina Therapeutics Inc Stock $ser

2022 Q3 Form 10-Q Financial Statement

#000149315222022361 Filed on August 12, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SER
Serina Therapeutics Inc Stock $ser